| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |